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Abstract
Background: K-Bungarotoxin (K-BTX) is a highly toxic snake
venom K-neurotoxin that binds to acetylcholine receptor (AChR)
at the neuromuscular junction, and is a potent inhibitor of this
receptor. We describe the design and synthesis of peptides that
bind K-BTX with high affinity, and inhibit its interaction with
AChR with an IC50 of 2 nM. The design of these peptides was
based on a lead peptide with an IC50 of 3U1037 M, previously
identified by us [M. Balass et al., Proc. Natl. Acad. Sci. USA 94
(1997) 6054] using a phage-display peptide library.
Results : Employing nuclear magnetic resonance-derived struc-
tural information [T. Scherf et al., Proc. Natl. Acad. Sci. USA 94
(1997) 6059] of the complex of K-BTX with the lead peptide, as
well as structure^function analysis of the ligand-binding site of
AChR, a systematic residue replacement of the lead peptide, one
position at a time, yielded 45 different 13-mer peptides. Of these,
two peptides exhibited a one order of magnitude increase in
inhibitory potency in comparison to the lead peptide. The design
of additional peptides, with two or three replacements, resulted in
peptides that exhibited a further increase in inhibitory potency
(IC50 values of 2 nM), that is more than two orders of magnitude
better than that of the original lead peptide, and better than that of
any known peptide derived from AChR sequence. The high
affinity peptides had a protective effect on mice against K-BTX
lethality.
Conclusions: Synthetic peptides with high affinity to K-BTX
may be used as potential lead compounds for developing effective
antidotes against K-BTX poisoning. Moreover, the procedure
employed in this study may serve as a general approach for the
design and synthesis of peptides that interact with high affinity
with any desired biological target. ß 2001 Elsevier Science Ltd.
All rights reserved.
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1. Introduction
The nicotinic acetylcholine receptor (AChR) is a ligand-
gated ion channel and is activated by binding of acetylcho-
line. K-Neurotoxins such as K-bungarotoxin (K-BTX) bind
speci¢cally to AChR and exhibit high toxicity due to in-
hibition of the AChR function at the neuromuscular junc-
tion. Synthetic peptides that bind K-BTX may yield com-
petitive inhibitors of K-BTX binding to AChR, and hence
result in potential lead compounds for e¡ective antidotes
against K-BTX poisoning. Moreover, since the K-neuro-
toxins bind AChR with very high a⁄nity and speci¢city,
understanding the nature of binding is obviously of con-
siderable importance in the study of the ligand-binding site
of AChR.
The ligand-binding site of AChR is located mainly at
the K-subunit, in the vicinity of Cys192 and Cys193 [3^5]
and partially overlaps with the binding domain for K-BTX
(Torpedo AChR residues 185^196) [6]. A synthetic peptide
corresponding to the sequence of Torpedo K185^196 was
found to bind agonists speci¢cally and to inhibit the bind-
ing of K-BTX to AChR with an IC50 of 1034 M [7]. A 13-
mer peptide corresponding to residues 187^199 exhibited
higher inhibition potency with an IC50 of 1036 M [1].
The aim of the present study was to design and prepare
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peptides that bind K-BTX with high a⁄nity and inhibit its
interaction with AChR, by taking into consideration the
available structural data (nuclear magnetic resonance,
NMR) and functional information on the system studied.
It was expected that the information acquired during this
procedure would shed new light on the nature of the
AChR residues that are responsible for binding K-BTX
and for determining the biological speci¢city of this inter-
action. Moreover, such an approach might lead to a gen-
eral procedure for the design and synthesis of peptides
having a desired highly speci¢c biological activity.
In a previous study [1] we employed a combinatorial
phage-display peptide library and identi¢ed a library-lead
peptide (MRYYESSLKSYPD) that binds speci¢cally K-
BTX and inhibits its binding to AChR with an IC50 in
the low micromolar range. This peptide contains the motif
YYXSS that is homologous to the AChR consensus motif
YYXCC, located at the ligand-binding site. The structure
of the complex between K-BTX and the library-lead pep-
tide was determined using two-dimensional 1H-NMR [2].
The bound peptide was found to adopt a globular con-
formation around a hydrophobic core created by a side
chain of Tyr11 of the peptide, whereas the free peptide in
solution was characterized by a rather random conforma-
tion. The amino acid residues that bind tightly with K-
BTX and/or interact internally with other residues in the
peptide were identi¢ed. These are Arg2, Tyr3, Tyr4, Glu5,
Ser6, Ser7, Leu8, Lys9, Ser10 and Tyr11 [2].
Additional information as to amino acid residues that
may be important for binding to K-BTX came from a
previous comparative sequence analysis of the AChR li-
gand-binding site from animal species that are sensitive
(mouse, Torpedo, chick) or resistant (snake, mongoose)
to K-BTX [8^10]. Such an analysis demonstrated major
amino acid di¡erences between sensitive and resistant ani-
mal species, in four residues at positions 187, 189, 194 and
197 of the AChR K-subunit [9]. A more recent study [11],
employing point-mutations in the K-subunit of mongoose
(resistant to K-BTX) and comparing them to the K-subunit
of mouse (sensitive to K-BTX) led to the de¢nition of two
subsites at the AChR-binding domain that are important
for binding of K-BTX: the proline subsite, which is critical
for binding and includes Pro194 and Pro197, and the ar-
omatic subsite, which includes residues 187 and 189.
In the present study we describe the design and synthe-
sis of a new peptide library based on adequate amino acid
residue replacements of some of the residues of the library-
lead peptide. In the design of this library, both structural
and functional available data were taken into considera-
tion. This study resulted in peptides that bind K-BTX with
high a⁄nity and inhibit its binding to AChR with an IC50
of 2 nM. The inhibition potency of the high a⁄nity pep-
tides is stronger by at least two orders of magnitude than
the inhibitions obtained by the original phage library-lead
peptide and also by a 13-mer peptide derived from the
binding site domain of AChR (K187^199). The paradigm
employed for this particular study can be used as a possi-
ble general procedure for the design and synthesis of de-
sired biologically active peptides, that might present a⁄n-
ities and speci¢cities even better than those of peptides
derived from naturally occurring proteins.
2. Results
2.1. Systematic single amino acid residue replacement
In an attempt to design peptides with increased a⁄nity
to K-BTX we ¢rst built a new peptide library derived from
the phage library-lead peptide (MRYYESSLKSYPD) [1]
by systematic single amino acid residue replacement. In
preparing this library we ¢rst took into consideration the
information available from the NMR analysis of the com-
plex of K-BTX with the library-lead peptide [2]. Table 1
summarizes the external and internal interactions of the
library-lead peptide in its complex with K-BTX [2]. As
Table 1
Inter- and intra-molecular interactions in the complex of the library-lead peptide and K-BTXa
Lead-peptide residue Contact area with K-BTX (Aî 2) Interacting K-BTX residues Atom type involved in intra-peptide interactionsb
M1 ^ ^
R2 46 V39 bb+sc (LCH2)
Y3 135 T6, A7, I11, V39, H68 bb+sc (Ar)
Y4 125 D30, R36, V39, V40 bb+sc (LCH2)
E5 104 K38, V39, V40, H68 bb
S6 ^ bb
S7 32 H68, R72 bb+sc (QOH)
L8 97 I11, H68, K70, Q71 ^
K9 ^ bb
S10 ^ bb
Y11 ^ sc (Ar)
P12 ^ ^
D13 ^ ^
aThe data were derived from the NMR solution structure of the complex [2].
bsc = side chain, bb = backbone, Ar = aromatic.
CHBIOL 60 7-3-01
148 Chemistry & Biology 8/2 (2001) 147^155
shown in Table 1, residues Arg2, Tyr3, Tyr4, Glu5, Ser7
and Leu8 of the lead-peptide form large contact areas with
K-BTX and were therefore conserved. In addition, in order
to stabilize the conformation of the bound peptide in the
complex, we retained residue Tyr11, which participates in
intra-molecular interactions within the peptide. Residues
Ser6, Lys9 and Ser10 contribute to intra-peptide interac-
tions only by backbone atoms, and therefore these posi-
tions were not conserved. Thus, in this series of peptides,
replacements were introduced at residues Met1, Ser6,
Lys9, Ser10, Pro12 and Asp13.
With the object of reducing the number of prepared
peptides to a few tens, the 20 natural amino acids were
categorized according to the chemical nature of their side
chains, as well as their classi¢cation as proposed elsewhere
[12,13]. Six groups of amino acids were suggested (see Fig.
1) as follows: amino acids with hydrophobic side-chains
(Ile, Val, Leu), amino acids with aromatic side-chains
(Phe, Trp, Tyr), amino acids with positively charged
side-chains (Lys, Arg, His), amino acids with negatively
charged side-chains or their corresponding amides capable
of hydrogen bonding (Asp, Glu, Asn, Gln). The ¢fth
group consisted of amino acids with the smallest side-
chain (Gly and Ala), and the sixth group was represented
by proline alone, since it a¡ects the backbone conforma-
tion in a unique way. Cysteine has an unusual structural
role in proteins, in which a disul¢de bond with a remote
cysteine residue is created. It was therefore excluded from
the six categories because we preferred not to involve cy-
clic peptides in the design. Serine, threonine and methio-
nine were also excluded in most cases, to reduce the num-
ber of peptides that is adequate to the multi-peptide
synthesizer (see Section 5).
Based on these considerations, a series of 38 peptides
was prepared by systematic residue replacement at posi-
tions 1, 6, 9, 10, 12 and 13 of the library-lead peptide, one
at a time, with one representative residue of each of the six
categories (Table 2). Three replacements were introduced
also in position Ser7, despite its participation in K-BTX
binding. Experiments on inhibition of the binding of K-
BTX to Torpedo AChR by the newly synthesized peptides
were carried out according to standard procedures (see
Section 5). The IC50 values were calculated and compared
with that of the original library-lead peptide that exhibited
an IC50 value of 3.3U1037 M. All peptides were ¢rst an-
alyzed in their crude form (40^90% purity) ; peptides of
special interest were puri¢ed by reversed-phase high per-
formance liquid chromatography (HPLC), and their inhi-
bition potencies were determined also in their puri¢ed
form. Although replacements were made one position at
a time, large di¡erences in inhibitory potencies were ob-
served between some of the peptides. As shown in Table 2,
seven peptides retained the same or slightly higher inhib-
Fig. 1. Suggested categorization of natural amino acids according to the
chemical nature of their side-chain.
Table 2
Inhibition of the binding of K-BTX to Torpedo AChR by the library-
lead peptide and by peptides 1^38, designed by systematic residue re-
placement of the library-lead peptidea
#HPLC puri¢ed peptide.
aAmino acid residues that were replaced in the library-lead peptide are
outlined.
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itory activity than that of the library-lead peptide (IC50 in
the range of 1U1037^3.0U1037 M). The activity of some
peptides was lower by 1^2 orders of magnitude, and four
peptides (No. 10, 13, 15 and 23) did not exhibit any de-
tectable inhibition. One peptide (No. 29) exhibited one
order of magnitude increase in the inhibitory activity
(IC50 of 3.2U1038 M) as compared with that of the li-
brary-lead peptide. Interestingly, this peptide represents a
replacement of Ser10 by Pro, which is the residue present
at this corresponding position in the neuronal K7 AChR
(see later).
It should be noted that replacement of Ser6 by Leu,
Lys, Thr or Gly yielded peptides with inhibitory potencies
of only one order of magnitude lower than that of the
original peptide, indicating that this position does not con-
tribute signi¢cantly to K-BTX binding. However, a re-
placement of this position by Asp or Pro resulted in pep-
tides No. 10 and 13 with no detectable inhibition. The
latter replacement (peptide 13) may result from alteration
of the backbone conformation. Finally, substitution of
Ser6 by Tyr (peptide 8, Table 2) resulted in a peptide
having inhibitory potency similar to that of the library-
lead peptide. It is of interest that the replacement of Ser7
by Tyr (No. 15, Table 2) abolished the inhibition. This
e¡ect might be explained by a steric hindrance caused by
repulsions between the side chains of Tyr7 and Tyr11,
since the side chains of the corresponding residues of the
library-lead peptide (Ser7 and Tyr11) are directed towards
the core of the peptide in its complex with K-BTX.
2.2. Single amino acid residue replacements based on amino
acid sequences of the AChR ligand-binding site
Additional peptides were synthesized based on data
available from a comparative analysis of amino acid se-
quences in the AChR-binding site of animal species that
are sensitive or resistant to K-BTX. We assumed that in-
corporation into the library-lead peptide of residues
uniquely present in the sensitive animal species might yield
peptides with an increased a⁄nity for K-BTX. Table 3
summarizes the amino acid sequences of residues 187^
200 of the K-subunit of several AChR species that are
sensitive or resistant to K-BTX [10]. The library-lead pep-
tide is described in alignment with the receptor sequences.
As reported earlier [8^10] and depicted in Table 3, Trp187
is important for K-BTX binding, since it is present in the
K-subunits of AChRs that bind K-BTX (mouse, chick,
Torpedo) and not in AChRs of non-sensitive species
(hedgehog, cobra, mongoose). In view of the importance
of Trp187 for K-BTX binding, we focused on the corre-
sponding position of the library-lead peptide (Met1). This
methionine in the library-lead peptide does not participate
in either external or internal molecular interactions when
the peptide is in complex with K-BTX [2] (Table 1). There-
fore, in an attempt to increase the a⁄nity of the library-
lead peptide for K-BTX, we prepared a peptide with Trp at
position 1 (peptide 39, Table 4), replacing Met. Peptide 39
indeed showed an IC50 of 3.5U1038 M, that is one order
of magnitude better than that of the original library-lead
peptide (3.3U1037 M; Table 4).
Val188 of the K-subunit is a conserved residue in all
receptor sequences (Table 3). This valine residue is prob-
ably not important for K-BTX binding, as it is present in
both K-BTX-sensitive and -resistant species. To verify this
point, we prepared a peptide that has Val at position 2
(peptide No. 40, Table 4). The inhibitory activity of pep-
tide No. 40 was decreased by one order of magnitude in
Table 3
Alignment of amino acid sequence of the library-lead peptide in com-
parison with the sequence of the K-BTX-binding region of muscle
AChR (position 187^200 in the K-subunit) from various animal species,
and with the amino acid sequence of neuronal K-subunit (K7) [11]a
aDots represent amino acid residues that are identical to the corre-
sponding positions in Torpedo AChR.
Table 4
Inhibition of the binding of K-BTX to Torpedo AChR by peptides 39^
47a
#HPLC puri¢ed peptide.
aAmino acid residues that were replaced in the library-lead peptide are
outlined.
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comparison to the library-lead peptide, suggesting that Val
at this position in AChR is probably not important for K-
BTX binding, and verifying that Arg2 in the peptide does
contribute to K-BTX binding, as reported previously from
NMR studies [2].
As reported earlier, position 194 in the AChR K-subunit
is occupied by proline in animal species sensitive to K-
BTX, whereas it is occupied by leucine in both snake
and mongoose, that are resistant species [8,9,11] (Table
3). Surprisingly, the phage library chose Leu in position
8 (correlated to AChR position 194), similar to that in
species resistant to K-BTX. Moreover, Leu8 of the li-
brary-lead peptide had been shown to contribute signi¢-
cantly to K-BTX binding [2] (Table 1). We assumed that
the similarity of position 8 in the peptide with position 194
in muscle AChR sequences of species that are resistant to
K-BTX (both snake and mongoose have Leu at this posi-
tion) is a coincidence. To verify this assumption, we pre-
pared a peptide with Pro at position 8 (peptide 43, Table
4). The inhibitory activity of this peptide was two orders
of magnitude lower than that of the library-lead peptide.
Replacement of Leu8 by Lys (peptide 45, Table 4) yielded
a peptide with no detectable binding, probably because of
electrostatic repulsion, as this position faces Lys70 of K-
BTX. Electrostatic repulsion might also be caused by the
presence of two adjacent positively charged residues in
peptide 45 (Lys8 and Lys9; see Table 4).
Alignment of residues 194^199 of the Torpedo muscle
AChR with the C-terminal part (residues 8^13) of the
library-lead peptide shows a poor sequence similarity
(see Table 3). Furthermore, a peptide whose N-terminus
contains seven amino acid residues of the library-lead pep-
tide, followed by seven residues corresponding to amino
acid residues 194^200 of the Torpedo muscle AChR,
showed no inhibitory e¡ect (peptide 46, Table 4). On the
other hand, alignment of residues 8^13 of the lead peptide
with residues 194^199 of the neuronal K7 AChR that binds
K-BTX, indicates a high sequence similarity (Table 3). We
therefore decided to rely for this part of the peptide on the
information available from neuronal K-BTX-binding
AChRs (Table 3). Indeed, as mentioned above (Table 2),
peptide 29, which contains Pro at position 10 replacing Ser
in the library-lead peptide, exhibited an inhibition of K-
BTX binding (IC50 = 3.2U1038 M) that is 10-fold stronger
in comparison to the library-lead peptide. Peptide 29 is
characterized by four C-terminal residues (PYPD) identi-
cal to residues at positions 196^199 of the neuronal rat K7
type AChR (Table 3). The high a⁄nity of peptide 29 (Ta-
bles 2 and 4) may indicate that Pro196 of the neuronal rat
K7 AChR plays an important role in its interaction with K-
BTX. Therefore, Pro196 and Pro198 might represent the
proline subsite [11] of the neuronal K-BTX-binding
AChRs.
2.3. Design of peptides having two or more replacements
In an attempt to further increase the inhibitory potency
of the peptides, we prepared a third series of peptides
based on the information obtained from peptides studied
thus far. This third series was based on the assumption
that a replacement of two residues or more in a single
peptide might yield peptides with a further increase in
a⁄nity. Among the 47 peptides described in Tables 2
and 4 (the second series), peptides 29 and 39 were the
most potent inhibitors of K-BTX binding to AChR. These
peptides (No. 39 and 29) were obtained by single replace-
ments of Met1Trp and Ser10Pro, respectively. Accord-
ingly, we prepared a peptide in which the corresponding
two amino acid replacements were carried out concomi-
tantly. As shown in Table 5, the resulting peptide (peptide
48) with the double replacement has an IC50 of 1U1038
M, which represents a 30-fold increase in the inhibitory
potency relative to the library-lead peptide
(IC50 = 3.3U1037 M), and three-fold increase in the a⁄n-
ity of either of the peptides with single replacements (pep-
tides 29 and 39). It thus shows that the two replacements
together, namely of Met1Trp and of Ser10Pro, did not
interfere with each other, and suggests that the a⁄nity
of the peptide for K-BTX could possibly be further im-
Table 6
Inhibition of binding of K-BTX to Torpedo AChR by peptides derived
from the K-subunit of muscle AChR (K1), neuronal AChR (K7) and
combinations of the two
Peptide IC50 (M) Source type
57 W V Y Y T CCP D T P Y L D 2.6U1038 K1 (muscle)
58 E K F Y E CCK E P Y P D 1.8U1035 K7 (neuronal)
59 E K F Y E S S K E P Y P D s 1033 K7 with Ser
60 E K F Y E S S P D T P Y L D no inhibition K7+K1
61 W V Y Y T S S K E P Y P D 1.5U1035 K1+K7
50 W R Y Y E S S L E P Y P D 2.0U1039a third series
aHPLC puri¢ed peptide, see Table 5.
Table 5
Inhibition of binding of K-BTX to AChR by peptides 48^56 obtained
by two or more amino acid residue substitutionsa
#HPLC puri¢ed peptide.
aAmino acid residues that were replaced in the library-lead peptide are
boxed.
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proved by introducing numerous replacements concomi-
tantly into the library-lead peptide.
We then prepared more peptides derived from peptide
48, with additional replacements. The list of peptides syn-
thesized in this series and their IC50 values for the inhibi-
tion of K-BTX binding to AChR are described in Table 5.
As shown, several peptides with increased a⁄nity for K-
BTX (IC50 in the low-nanomolar range) were obtained.
Peptides 49, 50, 52, 53 and 56, in all of which Lys9 in
the lead peptide was replaced by Asp or Glu (which are
the residues present at this position in neuronal K7
AChR), exhibited an IC50 of 1.6^3.8U1039 M. This inhi-
bition potency is more than two orders of magnitude bet-
ter than that of the library-lead peptide. Interestingly, re-
placing Lys9 by Leu (Table 5, peptide 54) resulted also in
increased a⁄nity (IC50 = 1.9U1039 M). Notably, introduc-
ing two adjacent cysteine residues replacing Ser6 and Ser7
(peptide 56) did not result in a binding coe⁄cient di¡erent
from that of peptide 49 (Table 5). On the other hand,
replacing these two serine residues of the library-lead pep-
tide yielded a peptide (peptide 55, Table 5) with a binding
activity considerably higher than that of the library-lead
peptide (IC50 = 3.3U1037 M).
2.4. Comparison of the binding coe⁄cients of the synthetic
peptides with those of peptides derived from AChR
The synthetic peptides depicted in Table 5 with IC50 in
the nanomolar range represent the best obtained inhibitors
of K-BTX binding to AChR. These peptides are signi¢-
cantly better inhibitors than the analogous peptides de-
rived from natural amino acid sequences (residues 187^
199) of either muscle (K1) or neuronal (K7) AChR ([1] ;
Table 6). It should be noted that even a 14-mer peptide
corresponding to residues 187^200 of the muscle AChR K-
subunit that includes Asp200 (IC50 = 2.6U1038 M [Balass,
personal communication] and peptide 57, Table 6) has an
IC50 that represents a one order of magnitude weaker in-
hibitory potency than that of peptides 49, 50, 52, 53, 54
and 56 (nanomolar range; Table 5). Asp200 probably
aligns with Asp199 in the neuronal AChR and Asp13 in
the lead peptide. This result shows that the systematic res-
idue replacement approach yielded peptides with high af-
¢nities that could not have been achieved by the prepara-
tion of peptides corresponding to the amino acid sequence
of the AChR-binding site.
Additional peptides were designed to represent various
combinations of muscle and nerve K-subunits (peptides
58^61, Table 6). Peptides 59^61 have AChR sequences in
which Cys192 and Cys193 are replaced by two Ser resi-
dues, as in the case of the library peptides. Peptide 59 is
derived from the neuronal K7 AChR (residues 187^199);
peptide 60 is a combination of the amino-end of the neu-
ronal K7 (residues 187^191) and the carboxyl-end of
muscle AChR (residues 194^200), and peptide 61 is a re-
versed combination of peptide 60. All of these combina-
tions yielded peptides with lower a⁄nities than either the
AChR-derived peptides (Table 6) and much lower than
those of the peptides obtained by the systematic residue
replacement (Table 5).
2.5. Biological activity of a high a⁄nity peptide
Peptides that bind toxins and inhibit binding to their
targets may be used as lead compounds for potential anti-
dotes against such poisons. It was therefore interesting to
examine if the high a⁄nity peptides designed in this work
would protect against K-BTX lethality in mice. Peptide
No. 50 was incubated with K-BTX for 1 h, and the mix-
ture was injected into mice. The peptide (5 mg per mouse)
conferred full protection from K-BTX (5 Wg) toxicity,
whereas control mice injected with K-BTX alone died 2 h
after injection. A dose of 1 mg peptide per mouse pro-
tected 25% of the mice, and 0.1 mg peptide did not confer
any protection.
3. Discussion
In this study we designed and prepared a series of pep-
tides that interact with high a⁄nity with K-BTX, and suc-
ceeded in obtaining peptides that bind K-BTX and inhibit
its binding to AChR with an IC50 of V2 nM. This inhi-
bition represents an a⁄nity that is more than two orders
of magnitude better than that of a previously described 13-
mer peptide, which was selected from a phage-display pep-
tide library and used as a lead-peptide.
Replacements of three positions in the library-lead pep-
tide resulted in the most signi¢cant increases in binding.
These included replacement of Met1 with Trp, Ser10 with
Pro, and Lys9 with Asp, Glu or Leu. A combination of
these three replacements resulted in peptides with an IC50
in the nanomolar range (Table 5). The replacement of
Met1 by Trp was introduced based on information ob-
tained from sequence data of muscle AChR. This Trp,
which corresponds to Trp187 in the muscle AChR K-sub-
unit, was shown to be important for K-BTX binding
[7,10,11]. Thus, this element in the high a⁄nity library
peptides comes exclusively from sequence data of muscle
AChR. It may be noted in this respect that the NMR-
derived structure of the library-lead peptide with K-BTX
[2] shows that Met1 of the peptide is located near Arg36 of
K-BTX; it is therefore possible that the indole ring of Trp
at this position interacts with the side chain of Arg36 in K-
BTX.
The replacement of Ser10 with Pro is based on sequence
alignment with the neuronal K7 AChR. The presence of
Pro10 and Pro12 in the high a⁄nity peptides represents
the proline subsite of the neuronal K7 AChR (Pro196 and
Pro198; see Table 3), and appears to be of critical impor-
tance in establishing the a⁄nity of this receptor to K-BTX.
It should be mentioned that systematic residue replace-
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ment based on NMR information (Table 2) also led to this
replacement. This highlights the possible general use of the
approach described in this work, since structural data can
be utilized in many biochemical systems, and is not unique
to toxin^receptor interactions.
The third replacement that was signi¢cant in increasing
the binding potency is Lys9 to Asp or Glu. Interestingly,
the library-lead peptide had a basic residue at this posi-
tion, whereas in both muscle and neuronal (K7) AChRs
there is an acidic residue (or sometimes a hydroxyl-side
chain residue Thr or Ser) at this position (Table 3).
Thus, this replacement incorporates sequence information
from both muscle and neuronal (K7) AChRs. Finally, it
should be noted that a substitution of Lys9 of the lead
peptide by Leu also enhanced the inhibitory e¡ect. In most
cases proline was found to a¡ect extremely the inhibitory
potency of the peptides : in positions that Pro contributes
for binding or enables correct folding of the peptide, a
replacement by Pro resulted in a signi¢cant increase in
inhibitory potency (peptide 29), whereas in other positions
(6 and 9) no inhibition was observed (peptides 13, 23).
The high a⁄nity peptides (Table 5) have the motif
EPYPD at their carboxyl-terminal end (residues 9^13).
This motif is identical to residues 195^199 of the neuronal
K7-subunit. The carboxyl-terminal acidic residue (Asp13)
of the library-lead peptide, as well as that of all high
a⁄nity peptides, was demonstrated to be close to Arg36
of K-BTX [2]. Replacement of this Asp with a positively
charged residue (Lys, peptide 36, Table 2) decreased the
inhibitory potency by two orders of magnitude. This result
may indicate the importance of Asp200 in muscle AChR
and of Asp199 in neuronal AChR in binding to K-BTX,
by forming electrostatic interactions with Arg36 of K-
BTX.
The library lead peptide has Leu at position 8, which
was shown by NMR analysis to interact with K-BTX [2].
Interestingly, this residue is di¡erent from either Pro or
Lys, that are present at this position in the muscle and in
neuronal AChR that bind K-BTX (Table 3). Replacement
of this Leu by either Pro or Lys resulted in a signi¢cant
decrease in the a⁄nity (peptides 43 and 45, Table 4).
The increase of activity in the synthetic peptides was
obtained in this study by exploiting information available
from both muscle and neuronal AChR types, as well as
from the library-lead peptide itself. The peptides obtained
by the third series preparation (Table 5) inhibit the bind-
ing of K-BTX to AChR signi¢cantly better than any pep-
tide derived entirely from the receptors (see Table 6). The
higher a⁄nity suggests that the systematic residue replace-
ment is based on independent and di¡erent sources of
information, all of which lead to the required results.
In order to reduce the number of peptides to be pre-
pared, we made a general categorization of the 20 natural
amino acids. A systematic residue replacement of the lead
peptide was performed by using one representative amino
acid residue from each group. A larger library of peptides,
that includes more members of each category to replace
each position, might therefore yield peptides with better
inhibition potencies.
Peptide No. 50 had a protective e¡ect on mice in-vivo
against K-BTX lethality. As linear peptides undergo pro-
teolytic degradation in blood, an increase of the peptide
stability to proteolysis may improve its in vivo activity.
This may be achieved by cyclization through a disul¢de
bond, as previously described for other peptides with anti-
K-BTX in vivo activity [Balass et al., unpublished results]
or by other chemical modi¢cations.
In designing the peptides described in this study, we
applied the relevant available knowledge of the system
studied, including NMR-derived structural information
and functional information. The increase in activity was
achieved mainly by integrating data obtained from the
NMR solution structure of the complex between K-BTX
and the lead target peptide, together with information
from analysis of the AChR-binding domain in animal spe-
cies that are sensitive or resistant to K-BTX. By rationally
integrating these data in a systematic residue replacement
of the lead peptide, we were able to optimize the activity
using only a limited number of peptides. Additional infor-
mation, such as computer-assisted modeling, point-muta-
tions and X-ray structure determination, can in principle
be integrated in the procedure.
4. Signi¢cance
The present study describes rational design and synthe-
sis of peptides that bind K-BTX with high a⁄nity and
inhibit K-BTX binding to AChR with an IC50 of 2 nM.
These peptides may be used as lead compounds for the
development of antidotes against K-BTX poisoning, taking
into consideration the in-vivo protection of mice against
K-BTX poisoning observed with peptide No. 50. Based on
the success in obtaining peptides with high a⁄nity, we
propose a novel approach (shown below), termed system-
atic residue replacement, that may be used as a general
procedure for obtaining high a⁄nity peptides in any bio-
chemical system that contains a ligand and a receptor
molecule.
(1) Use of combinatorial chemical or biological random-
peptide libraries to detect a lead peptide that binds specif-
ically, even with a moderate a⁄nity, to a receptor mole-
cule. (2) Structure determination (by NMR or X-ray) of
the complex formed between the receptor molecule and
the lead peptide. If NMR and X-ray data are not avail-
able, computer modeling can be used to provide structural
information. (3) Systematic residue replacement of the
lead peptide, to yield a secondary library of peptides. To
minimize the number of peptides to be prepared by this
procedure, the general categorization of the 20 natural
amino acids suggested in this work (Fig. 1) may be used.
(4) Analysis of the amino acid sequences of natural ligand-
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binding sites, to identify the amino acid residues essential
for binding with the ligand. (5) Synthesis of new secondary
peptide libraries based on the new information acquired in
steps (2)^(4).
In conclusion, the procedure employed in this study
o¡ers a promising method for obtaining high a⁄nity pep-
tides, by integration of a random substitution technique
with structural and functional information. The random
techniques utilize combinatorial libraries to yield lead pep-
tides that bind speci¢cally to the relevant receptor. The
structural data acquired should provide information on
the three-dimensional structure of the receptor^lead pep-
tide complex. In addition, the functional biological infor-
mation, if available, should provide complementary data
of considerable importance.
5. Materials and methods
5.1. General peptide synthesis
All protected amino acids and coupling reagents were pur-
chased from Novabiochem (Laufel¢ngen, Switzerland). Solvents
for peptide synthesis were of synthesis-grade (Labscan; Dublin,
Ireland). The peptides were prepared by conventional solid-phase
peptide synthesis, using an ABIMED AMS-422 automated solid-
phase multiple peptide synthesizer (Langenfeld, Germany). The 9-
£uorenylmethoxycarbonyl (Fmoc) strategy was used throughout
the peptide chain assembly [14], following the company’s com-
mercial protocols. Wang resin, which contains the ¢rst covalently
bound corresponding N-Fmoc C-terminal amino acid (12.5 Wmol
in the preparation of peptides 1^47 and the library-lead peptide,
and 25 Wmol in all other preparations) was used in each reaction
vessel (polymer loading of 0.55^0.76 mmol/g). Side chain protect-
ing-groups were tert-butyloxycarbonyl for Lys and Trp; trityl for
Asn and Cys; tert-butyl-ester for Asp and Glu; tert-butyl ether
for Ser, Tyr and Thr and pentamethyldihydrobenzofuran-5-sul-
fonyl for Arg.
Coupling for the preparation of 12.5 Wmol peptides was carried
out by using two successive reactions with 50 Wmol (4 equiv.) of
the corresponding N-Fmoc amino acid, 50 Wmol (4 equiv.) of
benzotriazole-1-yl-oxy-tris-pyrolidino-phosphonium hexa£uoro-
phosphate reagent, and 100 Wmol (8 equiv.) of 4-methyl-morpho-
line, all dissolved in dimethylformamide for 20^45 min at room
temperature. For the preparation of 25 Wmol peptides the same
equivalents of the reagents were used.
Cleavage of the peptides from the polymer was performed
usually by reacting the resin with 1.8 ml tri£uoro-acetic acid
(TFA)/H2O/triethylsilane (TES) at volume ratios of 90/5/5 for
2 h at room temperature. Peptides that contain Cys or Met were
treated with TFA/H2O/TES/thioanisole (85/5/5/5, v/v), whereas
peptides that contain both Trp and Arg were treated with
TFA/H2O/thioanisole/ethane-dithiol/phenol (87.5/5/5/2.5/trace
amount, v/v). The cleavage mixtures were cooled down to 4‡C,
the peptides were precipitated with ice-cold di-tert-butyl ether and
centrifuged for 10^15 min, 3000 rpm at 4‡C. The pellet was
washed and centrifuged three times with di-tert-butyl ether, dis-
solved in 30% acetonitrile in water, and lyophilized.
5.2. Reversed-phase HPLC
Purity validation of synthetic peptides was performed by ana-
lytical reversed-phase HPLC using a prepacked Lichrospher-100
RP-18 column (4U250 mm, 5 Wm bead size) employing a binary
gradient of 0.1% TFA in water (solution A) and 0.1% TFA in
75% acetonitrile in water (solution B) eluted at t = 0 min, B = 5%;
t = 5 min, B = 5%; t = 45 min, B = 95% (£ow rate 0.8 ml/min). The
chromatographic separation was performed using a Spectra-
Physics P200 liquid chromatography system equipped with a
Spectra-Physics UV100 variable wavelength absorbance detector
and AS100 auto sampler. The chromatograms were recorded on a
PE Nelson integrator model 1022. The purities of the crude pep-
tides were in the range of 40^90%.
Peptides of special interest (the library-lead peptide and pep-
tides No. 29, 39, 48, 50, 52, 54 and 56) were puri¢ed by using a
prepacked LiChroCart RP-18 column (10U250 mm, 7 Wm bead
size) using the same bu¡er system as described above except that
the gradient was of t = 0 min, B = 20%; t = 15 min, B = 20%;
t = 50 min, B = 60% (£ow rate 5 ml/min). Peptide puri¢cations
were performed using a Spectra-Physics SP8800 liquid chroma-
tography system equipped with SP8500 dynamic mixer and an
Applied Biosystems 757 variable wavelength absorbance detector.
The chromatograms were recorded on a Chrom-Jet integrator.
HPLC-puri¢ed peptides were s 98% pure. All column e¥uents
were monitored by UV absorbance at 220 nm; solvents and
HPLC columns were obtained from Merck (Darmstadt, Ger-
many).
5.3. Mass spectrometry
The HPLC-puri¢ed peptides were analyzed by time-of-£ight
(TOF) mass spectrometry using a VG matrix-assisted laser de-
sorption ionization TOF mass spectrometer (VG Fisons, Altrin-
cham, UK), and were found to exhibit the calculated mass. In-
sulin was used as a standard.
5.4. Biotinylation of K-BTX
HPLC-puri¢ed K-BTX from the snake venom of Bungarus mul-
ticinctus was purchased from Sigma (product number T3019).
For biotinylation, 100 Wg of K-BTX in 100 Wl of 0.1 M NaHCO3
pH 8.6, were incubated for 1 h at room temperature with 2.5 Wg
of biotin amido caproate N-hydroxysuccinimide ester (Sigma,
B2643) taken from a stock solution of 2 mg/ml in dimethylfor-
mamide. The reaction mixture was dialyzed overnight at 4‡C
against phosphate-bu¡ered saline (PBS; 0.14 M NaCl, 0.01 M
phosphate bu¡er, pH 7.4).
5.5. Inhibition of the binding of K-BTX to Torpedo AChR by the
peptides
AChR from the electric organ of Torpedo californica was solu-
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bilized with Triton X-100 and puri¢ed as described [15]. Inhibi-
tion of the binding of K-BTX to AChR by the peptides was
carried out as follows: Torpedo AChR (0.25 Wg/ml, in PBS)
was coated on an enzyme-linked immunosorbent assay plate (50
Wl per well) overnight at 4‡C. After washing with 0.05% Tween-20
in PBS (PBS/T), the wells were blocked with a solution of 1.5%
bovine serum albumin (BSA) and 1.5% hemoglobin (in PBS),
incubated for 2 h at room temperature and then washed with
PBS/T. Stock solutions of the individual peptides (1 mg/ml water
adjusted to pH 7 with 0.5 N NaOH and 0.2 N HCl) were diluted
to various concentrations with 1% hemoglobin in PBS, and in-
cubated with biotinylated K-BTX (50 ng/ml) for 30 min at 37‡C,
prior to their addition to the receptor-coated wells. After wash-
ings (PBS/T), the wells were incubated with alkaline phosphatase
conjugated extravidin (BioMakor, Israel ; 1:2000, in 1% BSA/
PBS) for 50 min at room temperature. The non-bound conjugate
was washed (PBS/T), and the bound biotinylated K-BTX was
monitored by the enzymatic reaction of alkaline phosphatase,
using the substrate p-nitrophenyl-phosphate (1 mg/ml in etha-
nol-amine bu¡ered saline; 33.9 g/l NaCl, 0.104 g/l MgCl2, 0.6
ml/l mono ethanol amine, pH 9.5). The color developed after
50 min at room temperature was determined, using a tunable
OPTImax microplate reader (Molecular devices, Sunnyvale,
CA, USA) at 405 nm. The concentration that resulted in 50%
inhibition of K-BTX binding to AChR (IC50) was determined for
each peptide. All peptides were ¢rst analyzed in their crude form
(40^90% purity). Peptides of special interest were puri¢ed by
reversed-phase HPLC, and their inhibition potencies were deter-
mined also in their puri¢ed form (see Tables 2 and 4^6).
5.6. Inhibition of the lethal e¡ect of K-BTX in mice by peptide
No. 50
The in-vivo experiments were carried out on groups of four
mice (Balb/c, 3 weeks old). A solution of K-BTX (5 Wg) and
peptide No. 50 in 1 ml PBS was preincubated for 1 h at room
temperature and injected subcutaneously into each mouse. A con-
trol group of mice that were treated with 5 Wg K-BTX alone
became paralyzed and died 2 h after the injection.
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